Skip to content

Bayer

Recent events

Recent events tied to this brand in public sources.

Back to profile95 entries · Page 2 of 5

  1. 2023

    Bayer settles New York Roundup advertising claims

    Bayer agreed to pay $6.9 million to settle New York's allegations that its Monsanto unit made false and misleading safety claims about Roundup. The settlement also requires the companies to remove or discontinue certain advertisements.

  2. 2023

    Bayer and Oerth Bio announce crop-protection collaboration

    Bayer and Oerth Bio announced a new collaboration to develop next-generation, more sustainable crop-protection products using Oerth Bio's protein-degradation technology.

  3. 2023

    Bayer announces Bill Anderson as new CEO

    Bayer announced Bill Anderson's appointment as its new CEO, signalling the exit of current CEO Werner Baumann.

  4. 2023

    Bayer announces acquisition of Blackford Analysis

    Bayer announced its acquisition of Blackford Analysis Ltd., a global imaging AI platform and solutions provider. The transaction was expected to close later in 2023, subject to customary closing conditions, including a UK competition regulator condition precedent.

  5. 2022

    Bayer Malawi launches DKC80-23 maize seed variety

    Bayer Malawi launched DKC80-23, a maize seed variety also named Mzati the Pillar. The company said it would be available nationwide for the 2022–23 agronomic season.

  6. 2022

    Bayer and Perdue AgriBusiness announce regenerative farming collaboration

    Bayer and Perdue AgriBusiness announced a collaboration to support regenerative farming among Perdue grain farmers and pursue carbon-emission reductions across Perdue’s grain network.

  7. 2022

    Bayer launches Kerendia in India

    Bayer launched finerenone, sold under the brand name Kerendia, in India to treat chronic kidney disease associated with type-2 diabetes.

  8. 2022

    Bayer launches ForGround digital farming platform

    Bayer launched ForGround, a digital farming platform intended to help U.S. growers adopt environmentally friendly practices and connect them with companies seeking more sustainable ingredients.

  9. 2022

    Bayer sues Perrigo over Nasonex advertising

    Bayer Healthcare LLC filed a complaint against Perrigo Company plc alleging that claims in Nasonex labeling and advertisements, including that it works twice as fast as other anti-allergy medications, are false and misleading. Bayer seeks an injunction, corrective advertising and damages; the source does not report a court determination.

  10. 2022

    Grünenthal announces acquisition of Nebido from Bayer

    Grünenthal announced that it was acquiring the Nebido testosterone treatment from Bayer AG for up to €500 million. The source describes Nebido as available to patients in more than 80 markets worldwide.

  11. 2022

    IQ-AI software becomes available on Bayer Calantic

    IQ-AI said its IB Clinic medical imaging analysis software is now available on the Bayer Calantic platform, in a partnership intended to make the software accessible through global networks.

  12. 2022

    Bayer announces Calantic digital solution launch

    Bayer announced the launch of Calantic, a digital platform offering AI medical-imaging applications. The initial launch markets are the United States and some European countries.

  13. 2022

    UPL and Bayer agree on global Spirotetramat supply and collaboration

    UPL announced a long-term global data access and supply agreement with Bayer for Spirotetramat. UPL said it will use its expertise and research network to develop, register and distribute new solutions containing the insecticide.

  14. 2022

    Bayer signs Zero Hunger Private Sector Pledge

    Bayer announced that it had signed the Zero Hunger Private Sector Pledge and would support it with 160 million U.S. dollars.

  15. 2022

    Bayer reaches $80 million PCB settlement with Ohio

    Bayer reached an $80 million settlement with Ohio to resolve alleged environmental damage attributed to PCBs made by its Monsanto business. Bayer did not admit liability and said Monsanto had not manufactured PCBs in Ohio or discharged them into Ohio waterways.

  16. 2022

    Bayer suspends most operations in Russia and Belarus

    Bayer suspended all activities in Russia and Belarus except those involving vital products for health and agriculture.

  17. 2022

    Bayer announces sale of its Environmental Science Professional business

    Bayer said it is selling its Environmental Science Professional business to private equity firm Cinven for $2.6 billion. The sale was expected to close in the second half of 2022.

  18. 2022

    Lawsuit alleges defects in Bayer's Essure device

    A plaintiff sued Bayer and related entities, alleging that defects in the Essure birth control device and its manufacturing could harm users. The allegations are described in the complaint; the article does not report a court determination.

  19. 2022

    Los Angeles files PCB contamination lawsuit against Monsanto

    The city of Los Angeles sued Monsanto and two other companies seeking compensation for past and future costs related to PCB contamination of waterways. The city alleges that PCBs continue to enter local waterways and soils. Bayer said it was reviewing the lawsuit and believed it was without merit, and denied that Monsanto manufactured, used, or disposed of PCBs in Los Angeles waters.

  20. 2022

    Bayer and Janssen sue Micro Labs over Xarelto patents

    Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals Inc. filed a patent-infringement case against Micro Labs LTD and Micro Labs USA Inc. concerning Xarelto. The plaintiffs seek declaratory and injunctive relief and expenses.